These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 12557764

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Investigation on the mechanics of adhesion to the selective extracellular matrix coated surfaces of lung cancer cells].
    Zhang T, Qu Q, Xue Y, Wu Z, Song G, Cai S.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Jun; 18(2):320-2, 333. PubMed ID: 11450565
    [Abstract] [Full Text] [Related]

  • 23. [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma].
    Zhu RX, Lin JS, Song YH, Li PY, Tao LW.
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):261-4. PubMed ID: 16875623
    [Abstract] [Full Text] [Related]

  • 24. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.
    Park MY, Kim KR, Park HS, Park BH, Choi HN, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS.
    Int J Oncol; 2007 Dec; 31(6):1309-15. PubMed ID: 17982656
    [Abstract] [Full Text] [Related]

  • 25. [Tropism of adult liver stem cells toward hepatocellular carcinoma cells in vitro].
    Zhong XG, He S, Yin W, Deng JY, Chen B.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):644-7. PubMed ID: 16174449
    [Abstract] [Full Text] [Related]

  • 26. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.
    Liu HL, Huo L, Wang L.
    Acta Pharmacol Sin; 2004 Oct; 25(10):1380-6. PubMed ID: 15456543
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma.
    Higashi Y, Suzuki S, Sakaguchi T, Nakamura T, Baba S, Reinecker HC, Nakamura S, Konno H.
    J Surg Res; 2007 May 01; 139(1):68-76. PubMed ID: 17270214
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
    Moran DM, Mayes N, Koniaris LG, Cahill PA, McKillop IH.
    Liver Int; 2005 Apr 01; 25(2):445-57. PubMed ID: 15780071
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Expression and significance of hypoxia inducible factor-1 alpha in hepatocellular carcinoma tissues].
    Zhang FJ, Tang WX, Wu CH, Yan W, Gu H.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr 01; 14(4):281-4. PubMed ID: 16635298
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T, Tokuda M, Yoshida S, Nakai S, Morishita A, Uchida N, Funaki T, Kita Y, Funakoshi F, Nonomura T, Himoto T, Deguchi A, Kimura Y, Izuishi K, Wakabayashi H, Usuki H, Yoshiji H, Watanabe S, Kurokohchi K, Kuriyama S.
    Int J Oncol; 2005 Mar 01; 26(3):661-71. PubMed ID: 15703821
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.